Market Overview

Karyopharm Therapeutics Prices 6.8M Share IPO at $16.00/Share

Share:

Karyopharm Therapeutics (NASDAQ: KPTI) today announced the pricing of its initial public offering of 6,800,000 shares of its common stock at a public offering price of $16.00 per share. All of the shares of common stock are being offered by Karyopharm. In addition, Karyopharm has granted the underwriters a 30-day option to…Karyopharm Therapeutics today announced the pricing of its initial public offering of 6,800,000 shares of its common stock at a public offering price of $16.00 per share. All of the shares of common stock are being offered by Karyopharm. In addition, Karyopharm has granted the underwriters a 30-day option to purchase up to an additional 1,020,000 shares of common stock at the same price, less the underwriting discount. The company's shares are expected to begin trading on the NASDAQ Global Select Market on November 6, 2013 under the ticker symbol "KPTI".

The offering is expected to close on November 12, 2013, subject to customary closing conditions.

BofA Merrill Lynch and Leerink Swann LLC are acting as joint book-running managers for the offering. JMP Securities LLC and Oppenheimer & Co. are acting as co-managers.

A registration statement relating to the securities being sold in this offering was declared effective by the Securities and Exchange Commission on November 5, 2013. When available, copies of the final prospectus may be obtained from BofA

See full press release

Posted-In: News Guidance Offerings IPOs Global

 

Related Articles

View Comments and Join the Discussion!